DEA's 2nd Annual Supply Chain Conference

Attention iodine market professionals!

As you know, iodine is a vital ingredient in many medications and is also classified as a DEA List 1 controlled substance. This strict regulation ensures the safe and secure distribution of iodine for legitimate purposes.

To help industry professionals stay informed and compliant, the Drug Enforcement Administration (DEA) recently held its 2nd Annual Supply Chain Conference. This valuable event provided a platform for discussions on regulations, best practices, and preventing diversion within the pharmaceutical supply chain, including crucial topics related to iodine distribution.

Missed the conference? No worries! The presentations from all three days are now available online for your reference. This is a fantastic opportunity to learn from DEA experts on a wide range of subjects directly connected to your work, including:

• Registration program updates to ensure compliance and streamline the process for iodine distribution.

• The 303 process for DEA registration and best practices for maintaining compliance.

• Import/export procedures for controlled substances, including iodine.

• Preparing for a DEA inspection to ensure a smooth and successful process for your iodine-related operations.

• DEA reporting requirements through tools like DTL (Diversion Tracking System) and SORS (Suspicious Order Report System), which are crucial for monitoring and preventing diversion of iodine.

• Current trends in drug shortages and how they impact the supply chain, including potential implications for iodine availability.

Access the DEA's 2nd Annual Supply Chain Conference presentations here: https://www.deadiversion.usdoj.gov/mtgs/supply_chain/conf_2024.html

By attending these virtual presentations and staying informed about regulations, iodine market professionals can play a vital role in ensuring the safe and responsible distribution of this essential medication component. Hope this helps! -Dr. Sakharov